Additional file 1: of Randomized, double-blind, placebo-controlled phase III study of ixazomib plus lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma: China Continuation study

Authors :: Hou, Jian
Jin, Jie
Xu, Yan
Depei Wu
Xiaoyan Ke
Daobin Zhou
Lu, Jin
Du, Xin
Xiequn Chen
Junmin Li
Liu, Jing
Gupta, Neeraj
Hanley, Michael
Hongmei Li
Zhaowei Hua
Bingxia Wang
Xiaoquan Zhang
Wang, Hui
Velde, Helgi Van De
Richardson, Paul
Moreau, Philippe
Publication Year :: 2017
Publisher :: Figshare, 2017.
Abstract: Supplementary methods. Hou C16010 China Continuation study J Hematol Oncol. (DOCX 38 kb)

Full Text Access

Tools